[{"address1": "99 High Street", "address2": "30th Floor", "city": "Boston", "state": "MA", "zip": "02110", "country": "United States", "phone": "617 300 8460", "website": "https://praxismedicines.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company's platforms include cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and solidus to discover and develop antisense oligonucleotide. It also develops Ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase 3 clinical trial for the treatment of essential tremor; Vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; Relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020 to treat KCNT1; and PRAX-050. In addition, the company develops Elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080 that targets PCDH19-related developmental epilepsy; PRAX-090 for targeting SYNGAP1 loss-of-function; and PRAX-100 that targets SCN2A LoF mutations. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.", "fullTimeEmployees": 116, "companyOfficers": [{"maxAge": 1, "name": "Mr. Marcio Silva De'Souza M.B.A.", "age": 44, "title": "President, CEO & Director", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 1179148, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy Edwin Kelly", "age": 51, "title": "CFO & Treasurer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 691583, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Nemiroff J.D.", "age": 45, "title": "General Counsel & Secretary", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 577338, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven  Petrou B.Sc. (Hons.), Ph.D.", "title": "Co-Founder & Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lauren  Mastrocola", "title": "VP of Finance & Principal Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karl  Hansen Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Kane", "title": "VP of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  McCue", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alyssa J. S. Wyant", "age": 49, "title": "Chief Regulatory & Quality Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan T. Sniecinski", "age": 42, "title": "Chief Business Officer", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 38.06, "open": 38.76, "dayLow": 38.365, "dayHigh": 40.84, "regularMarketPreviousClose": 38.06, "regularMarketOpen": 38.76, "regularMarketDayLow": 38.365, "regularMarketDayHigh": 40.84, "payoutRatio": 0.0, "beta": 2.676, "forwardPE": -3.6883595, "volume": 511850, "regularMarketVolume": 511850, "averageVolume": 551569, "averageVolume10days": 425910, "averageDailyVolume10Day": 425910, "bid": 29.21, "ask": 48.64, "bidSize": 2, "askSize": 2, "marketCap": 811367232, "fiftyTwoWeekLow": 26.7, "fiftyTwoWeekHigh": 91.83, "priceToSalesTrailing12Months": 94.863464, "fiftyDayAverage": 38.9795, "twoHundredDayAverage": 60.568874, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 376215296, "profitMargins": 0.0, "floatShares": 16083216, "sharesOutstanding": 20163200, "sharesShort": 1847505, "sharesShortPriorMonth": 2060595, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0916, "heldPercentInsiders": 0.00456, "heldPercentInstitutions": 1.10914, "shortRatio": 3.31, "shortPercentOfFloat": 0.091800004, "impliedSharesOutstanding": 20163200, "bookValue": 22.935, "priceToBook": 1.7545238, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -182819008, "trailingEps": -10.21, "forwardEps": -10.91, "lastSplitFactor": "1:15", "lastSplitDate": 1701216000, "enterpriseToRevenue": 43.986, "enterpriseToEbitda": -1.883, "52WeekChange": -0.24289745, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 40.24, "targetHighPrice": 270.0, "targetLowPrice": 26.0, "targetMeanPrice": 98.81818, "targetMedianPrice": 85.0, "recommendationMean": 1.63636, "recommendationKey": "buy", "numberOfAnalystOpinions": 11, "totalCash": 392567008, "totalCashPerShare": 19.469, "ebitda": -199807008, "totalDebt": 1369000, "quickRatio": 10.455, "currentRatio": 10.769, "totalRevenue": 8553000, "debtToEquity": 0.307, "revenuePerShare": 0.478, "returnOnAssets": -0.43815, "returnOnEquity": -0.70981, "grossProfits": -143860000, "freeCashflow": -69942128, "operatingCashflow": -131757000, "revenueGrowth": 13.491, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -8.56974, "financialCurrency": "USD", "symbol": "PRAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 5.727799, "regularMarketPrice": 40.24, "longName": "Praxis Precision Medicines, Inc.", "shortName": "Praxis Precision Medicines, Inc", "exchange": "NMS", "messageBoardId": "finmb_409236524", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "fiftyTwoWeekRange": "26.7 - 91.83", "fiftyTwoWeekHighChange": -51.59, "fiftyTwoWeekHighChangePercent": -0.561799, "fiftyTwoWeekChangePercent": -24.289745, "earningsTimestamp": 1746189000, "earningsTimestampStart": 1746189000, "earningsTimestampEnd": 1746189000, "earningsCallTimestampStart": 1730898000, "earningsCallTimestampEnd": 1730898000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -10.21, "epsForward": -10.91, "epsCurrentYear": -12.4818, "priceEpsCurrentYear": -3.2238941, "fiftyDayAverageChange": 1.2605019, "fiftyDayAverageChangePercent": 0.032337558, "twoHundredDayAverageChange": -20.328873, "twoHundredDayAverageChangePercent": -0.33563232, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-16", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1602855000000, "postMarketChangePercent": -0.0248562, "postMarketPrice": 40.23, "postMarketChange": -0.0100021, "regularMarketChange": 2.1800003, "regularMarketDayRange": "38.365 - 40.84", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 551569, "fiftyTwoWeekLowChange": 13.540001, "fiftyTwoWeekLowChangePercent": 0.50711614, "corporateActions": [], "postMarketTime": 1746230226, "regularMarketTime": 1746216000, "displayName": "Praxis Precision Medicines", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]